Search Results - "Awidi M"

Practical approaches to inclusive recruitment practices in Parkinson's disease research.

Authors: Chahine, Lana M Louie, Naomi Disbrow, Elizabeth et al.

Source: Journal of Parkinson's Disease. Jun2026, Vol. 16 Issue 4, p709-722. 14p.

Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis.

Authors: Muhanna Z Al Zyoud M Issa A et al.

Source: Targeted oncology [Target Oncol] 2025 Nov; Vol. 20 (6), pp. 1015-1022. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Authors: Awidi M Mier-Hicks A Perimbeti S et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2024 Sep; Vol. 25 (6), pp. 509-518. Date of Electronic Publication: 2024 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.

Authors: Pina-Cabral, Tiago Pereira, José Paulo-Fernandes, João et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p76. 20p.

Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023.

Authors: Gong, Inna Y. Rafinejad-Farahani, Bahar Majeed, Haris et al.

Source: Leukemia & Lymphoma. Jan2026, Vol. 67 Issue 1, p176-189. 14p.

Community perspectives on cancer and cancer research: findings from listening sessions with diverse groups in Philadelphia.

Authors: Glanz, Karen Soliva, Emma Adelia Scheffey, Krista et al.

Source: Discover Public Health. 6/9/2025, Vol. 22 Issue 1, p1-10. 10p.

Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non--Small Cell Lung Cancer: A Retrospective, Single-Center Study.

Authors: Thurman, Allison L. Storey, Susan Reeves, David J.

Source: Journal of Hematology Oncology Pharmacy. Jun2026, Vol. 16 Issue 3, p96-107. 12p.

"The more I know, the more you know" Using culturally responsive marketing strategies to develop tools that increase awareness about clinical trials among Black communities.

Authors: Henderson, Vida Carnahan, Leslie Cohn, Eliza Brumer et al.

Source: BMC Public Health. 9/1/2025, Vol. 25 Issue 1, p1-10. 10p.

CodeBreak 200: study limitations, and future directions.

Authors: Alharbi M Awidi M Dy GK

Source: Translational cancer research [Transl Cancer Res] 2024 Jan 31; Vol. 13 (1), pp. 15-21. Date of Electronic Publication: 2024 Jan 05.

Publication Type: Editorial; Comment

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE

Callback time preference for prescreening visits among Black residents in the Boston area: findings from two randomized controlled trials.

Authors: Zeto, Ruth Ibikunle, Oluwagbemisola Cao, Jingyi et al.

Source: Trials. 8/8/2025, Vol. 26 Issue 1, p1-11. 11p.

Effectiveness of Second-Line Pembrolizumab Monotherapy for the Treatment of Nonsmall Cell Lung Cancer: A Retrospective-Single Institution Study of 52 Vietnamese Patients.

Authors: Tai Nguyen, Van Kien Do, Hung Van Le, Quang et al.

Source: Clinical Medicine Insights: Oncology. 8/7/2025, p1-11. 11p.

A Formative Evaluation of Interventions to Enhance Clinical Trial Diversity Guided by the Socioecological Model.

Authors: Garcia, Melany Geiss, Carley Blackwell, Rebecca et al.

Source: Cancers. Jul2025, Vol. 17 Issue 14, p2282. 19p.

Shrinking Giants: On the Feasibility of Downsizing Hepatocellular Carcinoma with Immunotherapy Prior to Liver Transplantation.

Authors: Prejac, Juraj Kekez, Domina Lučev, Hana et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3923. 26p.

Anti-Tumor Immunity in Solid-Organ Transplant Recipients.

Authors: Wong, Jeffrey Sum Lung Li, Karen Hoi Lam Li, Bryan et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1216. 29p.

Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.

Authors: Osataphan S Awidi M Jan YJ et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Dec; Vol. 198, pp. 108023. Date of Electronic Publication: 2024 Nov 15.

Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Beyond the Guinea Pig Myth: Understanding Complex Attitudes Toward Clinical Trials Participation in a Community Clinic.

Authors: Murrell JE Allgood A Tamhane A et al.

Source: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2026 Apr; Vol. 41 (2), pp. 277-286. Date of Electronic Publication: 2025 May 31.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: England NLM ID: 8610343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-0154 (Electronic) Linking ISSN: 08858195 NLM ISO Abbreviation: J Cancer Educ Subsets: MEDLINE

KRAS G12C突变晚期非小细胞肺癌治疗研究 进展.

Alternate Title: Therapeutic Progress in Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer.

Authors: 刘义 黄臻 陈露露 et al.

Source: Cancer Research on Prevention & Treatment. Dec2025, Vol. 52 Issue 12, p1012-1020. 9p.

Identifying locally actionable strategies to increase participant acceptability and feasibility to participate in Phase I cancer clinical trials.

Authors: Staras, Stephanie A. S. Wollney, Easton N. Emerson, Lisa E. et al.

Source: Health Expectations. Feb2024, Vol. 27 Issue 1, p1-11. 11p.

Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center.

Authors: Moreland, Katie Butsch Kovacic, Melinda Rai, Shesh et al.

Source: Current Oncology. Sep2024, Vol. 31 Issue 9, p5367-5373. 7p.

Cardiotoxic Effects of Osimertinib Compared to Other EGFR Inhibitors: A Systematic Review and Meta-Analysis.

Authors: Garcia A Kayani AMA Navarro-Martinez DA et al.

Source: Cardiovascular toxicology [Cardiovasc Toxicol] 2026 Mar 09; Vol. 26 (3). Date of Electronic Publication: 2026 Mar 09.

Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 101135818 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0259 (Electronic) Linking ISSN: 15307905 NLM ISO Abbreviation: Cardiovasc Toxicol Subsets: MEDLINE